estimate total numbers of colony-forming units/ml after growth overnight at 37°C. Estimation of the numbers of rifampicin resistant colonies was made by plating 100 µl of the mid-log phase culture onto LB containing 15 μg/ml rifampicin. Additionally 1 ml and 5 ml of the same culture were pelleted by centrifugation and each pellet resuspended in 100 µl of 56/2 salts prior to plating out onto LB containing 15 μg/ml rifampicin. Numbers of rifampicin resistant colonies were estimated after overnight growth at 37°C. The fraction of rifampicin resistant colonies was calculated by dividing the number of rifampicin resistant colonies by the total number of colonies after correcting for dilution factors. Viability of uvrd/rep cells was monitored using a plasmid loss assay as described previously (2) . The strains used were: (i) Remodelling assays were performed with either wild type UvrD or UvrDΔC, and using GreB to test for backtracking, as described in the main methods section. Lane 1 shows the stalled transcript product (+20) without addition of the chase nucleotides, whereas lanes 2, 3 and 4 show the transcripts formed following re-initiation of transcription using the chase and pulldown with streptavidin beads. Lane 2 shows the total transcript population (T), Lane 3 shows the free RNA transcripts released into the supernatant (S) and lane 4 shows the transcripts that remain associated with RNAP and the DNA template in the pellet (P). Lane 5 shows the effect of treating the pellet fraction with GreB which cleaves any transcripts that are in a backtracked
RNAP complex. Lane 6 shows the effect of a 2 nd nucleotide chase which will restart transcription following transcript cleavage by GreB. Lane 7 is a control to show the effect of the 2 nd chase step but without addition of the GreB factor. show equivalent experiments performed in the presence of wild type UvrD or UvrDΔC. Asterisks highlight the position of the principal transcripts that are released into solution by the action of UvrD. Note that these correspond with the position of prominent cleavage products formed by the action of GreB.
SFigure 6. Deletion of the C-terminal domain of UvrD does not impact on nucleotide excision repair, mismatch repair or the ability of cells to survive in the absence of Rep.
(A) ΔuvrD cells display increased sensitivity to 254 nm UV light as compared with uvrD + cells due to a defect in nucleotide excision repair (5) (compare also i with ii). In contrast, a chromosomal allele encoding UvrD lacking the C-terminal 73 amino acids, uvrD , does not confer increased sensitivity to UV (compare iii with i). This supports the conclusion that UvrD lacking the C-terminus can function in nucleotide excision repair (6) at least up to the highest UV dose tested here. uvrD + , uvrD and ΔuvrD strains are TB28 (MG1655 ΔlacIZYA uvrD + )(7), N6632 (MG1655 ΔlacIZYA ΔuvrD::dhfr) (2) and VE10 (MG1655 ΔlacIZYA uvrD (2, 9) . Viability can be monitored using a very low copy and highly unstable plasmid, pRC7, that encodes the lac operon and either uvrD or rep (2) .
Retention or loss of pRC7rep can be monitored in strains bearing a chromosomal deletion of the lac operon by blue/white screening on LB plates containing X-gal and IPTG (2, 7) . Sanders et al., Supplementary Figure 4 Sanders et al., Supplementary Figure 5 P P P P T S T P P P P T S P P P P T S 1st chase 
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